Top 5 Key Players companies in Diabetic neuropathy by Most Patent Filings in the Canada in 2021 – Discovery

Free Trial

The Diabetic neuropathy top 5 is Discovery PatSnap’ annual ranking of the top 5 Most Patent Filings Diabetic neuropathy Key Players in the Canada. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2021, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.

1	Xenon Pharmaceuticals, Inc.	British Columbia, Canada	Phenotype,Medicine,Health care, ...[+2]	Patent: 18
2	Neuromed Pharmaceuticals Ltd.	British Columbia, Canada	Health care	Patent: 9
3	Chlorion Pharma, Inc.	Quebec, Canada	Small molecule,Epilepsy,Chloride, ...[+2]	Patent: 8
4	Alectos Therapeutics, Inc.	British Columbia, Canada	Alzheimer's disease,Drug development,Medicine, ...[+1]	Patent: 3
5	ProMetic BioSciences Ltd.	Canada	Biopharmaceutical,Medicine	Patent: 3

Page generation time: Jun 22 2025

Top 5 Key Players companies in Diabetic neuropathy
by Most Patent Filings in the Canada in 2021

Key Players

Fast-growings

Startups & Unicorns

New Entrants

2022

2021

2020

2019

2018

Global

China

Japan

India

United States

Switzerland

United Kingdom

South Korea

Netherlands

Germany

Canada

Italy

Denmark

France

Spain

Most Patent Filings

Highest Patent Value

Most Patent Citation

Most Research Publications

Most Literature Citation

Most Market Reports

Most News Heat

Who we serve

Why Discovery

Social media

Try Discovery